24 results  1 of 2 

1 Second Primary Malignancy after Radioiodine Treatment of Thyroid Disease: Current Status
Jaetae Lee, Chae Moon Hong, Jeoung-Hee Ha
Int J Thyroidol.2023;16(1):101-110.   Published online 2023 May 30     DOI: http://dx.doi.org/10.11106/ijt.2023.16.1.101
      
2 Risk of Diabetes in Patients with Long-Standing Graves’ Disease: A Longitudinal Study
Eyun Song, Min Ji Koo, Eunjin Noh, Soon Young Hwang, Min Jeong Park, Jung A Kim, Eun Roh, Kyung Mook Choi, Sei Hyun Baik, Geum Joon Cho, Hye Jin Yoo
Endocrinol Metab.2021;36(6):1277-1286.   Published online 2021 December 16     DOI: http://dx.doi.org/10.3803/EnM.2021.1251
      
3 Current Status and Future Perspective of the Treatment for Radioiodine Refractory Differentiated Thyroid Cancer
Young Kee Shong
Int J Thyroidol.2021;14(2):98-111.   Published online 2021 November 30     DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.98
      
4 99mTc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities
Luca Giovanella, Gaetano Paone, Teresa Ruberto, Luca Ceriani, Pierpaolo Trimboli
Endocrinol Metab.2019;34(1):63-69.   Published online 2019 February 15     DOI: http://dx.doi.org/10.3803/EnM.2019.34.1.63
      
5 Management of Bleeding Induced by Tyrosine Kinase Inhibitor in Radioiodine Refractory Thyroid Cancer
Dong Yeob Shin
Int J Thyroidol.2018;11(2):71-74.   Published online 2018 November 30     DOI: http://dx.doi.org/10.11106/ijt.2018.11.2.71
      
6 Management of Severe Fatigue Induced by Tyrosine Kinase Inhibitor in Radioiodine Refractory Thyroid Cancer
Byeong-Cheol Ahn
Int J Thyroidol.2018;11(2):75-77.   Published online 2018 November 30     DOI: http://dx.doi.org/10.11106/ijt.2018.11.2.75
      
7 High Serum Levels of Thyroid-Stimulating Hormone and Sustained Weight Gain in Patients with Thyroid Cancer Undergoing Radioiodine Therapy
Hyo Jung Seo, June-Key Chung, Keon Wook Kang, E. Edmund Kim, Gi Jeong Cheon, Jin Chul Paeng, Dong Soo Lee, Young Joo Park, Do Joon Park, Jae Gol Choe
Int J Thyroidol.2016;9(1):19-28.   Published online 2016 May 20     DOI: http://dx.doi.org/10.11106/ijt.2016.9.1.19
   
8 Papillary Thyroid Carcinoma with Retropharyngeal Node Metastasis Demonstrating Negative I-131 but Positive FDG Uptake on PET/CT
Haiyoung Son, Hyun Jun Hong, Jegyu Ryu, Jeong Won Lee, Ra Gyoung Yoon, Ilkyun Lee
Korean J Endocr Surg.2016;16(1):18-23.   Published online 2016 March 15     DOI: http://dx.doi.org/10.16956/kjes.2016.16.1.18
      
9 Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
Seo Young Sohn, Hye Won Jang, Yoon Young Cho, Sun Wook Kim, Jae Hoon Chung
Endocrinol Metab.2015;30(4):531-542.   Published online 2015 December 31     DOI: http://dx.doi.org/10.3803/EnM.2015.30.4.531
      
10 Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer
Seunggyun Ha, So Won Oh, Yu Kyeong Kim, Do Hoon Koo, Young Ho Jung, Ka Hee Yi, June-Key Chung
J Korean Med Sci.2015;30(7):876-881.   Published online 2015 June 10     DOI: http://dx.doi.org/10.3346/jkms.2015.30.7.876
      
11 Effect of a Low Iodine Diet vs. Restricted Iodine Diet on Postsurgical Preparation for Radioiodine Ablation Therapy in Thyroid Carcinoma Patients
Chi Young Lim, Jung-Yeon Kim, Mi-Jin Yoon, Hang Seok Chang, Cheong Soo Park, Woong Youn Chung
Yonsei Med J.2015;56(4):1021-1027.   Published online 2015 June 5     DOI: http://dx.doi.org/10.3349/ymj.2015.56.4.1021
      
12 New Strategies for Combined Radioiodine Therapy in Refractory Thyroid Cancer
So Won Oh, Jin Chul Paeng, June-Key Chung
J Korean Thyroid Assoc.2015;8(1):26-35.   Published online 2015 May 4     DOI: http://dx.doi.org/10.11106/cet.2015.8.1.26
   
13 Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
June-Key Chung, Gi Jeong Cheon
Endocrinol Metab.2014;29(3):233-239.   Published online 2014 September 25     DOI: http://dx.doi.org/10.3803/EnM.2014.29.3.233
   
14 Radioiodine Therapy: Review of the Empiric Fixed Dose Approaches and Their Selective Applications
Mi Park Jung
J Korean Thyroid Assoc.2013;6(1):34-42.   Published online 2013 May 3     DOI: http://dx.doi.org/10.11106/jkta.2013.6.1.34
   
15 Methods and Clinical Efficacy of Dosimetry-Based Treatment in Radioiodine Therapy of Thyroid Cancer
Chul Paeng Jin, Chung June-Key
J Korean Thyroid Assoc.2013;6(1):43-48.   Published online 2013 May 3     DOI: http://dx.doi.org/10.11106/jkta.2013.6.1.43
   
16 RAI Treatment of Distant Metastasis of Thyroid Cancer
Wook Kang Keon
J Korean Thyroid Assoc.2013;6(1):49-55.   Published online 2013 May 3     DOI: http://dx.doi.org/10.11106/jkta2013.6.1.49
   
17 A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer
Ji Hun Jeong, Jeong Yeal Ahn, Soon Ho Park, Mi Jung Park, Kyung Hee Kim, Jun Shik Hong
Korean J Hematol.2012;47(3):225-228.   Published online 2012 September 25     DOI: http://dx.doi.org/10.5045/kjh.2012.47.3.225
      
18 Usefulness of Sialendoscopy for Sialadenitis after Radioactive Iodine Therapy
Jeong-Seok Choi, Jae-Yol Lim, Young-Mo Kim
J Korean Thyroid Assoc.2012;5(1):60-64.   Published online 2012 May 31     DOI: http://dx.doi.org/10.11106/jkta.2012.5.1.60
      
19 New Trends in Radioiodine Treatment for the Advanced Differentiated Thyroid Cancer
Gi Jeong Cheon
Korean J Endocr Surg.2011;11(3):139-145.   Published online 2011 September 30     DOI: http://dx.doi.org/10.16956/kjes.2011.11.3.139
      
20 Fifteen Years or Greater Follow-Up of Pediatric Differentiated Thyroid Cancer
A Ram Kim M.D., Chi Won Sung M.D., Young Sam Park M.D., Cheol Seung Kim M.D., Kab Tae kim M.D.
Korean J Endocr Surg.2010;10(1):34-38.   Published online 2010 March 18     DOI: http://dx.doi.org/10.16956/kjes.2010.10.1.34
   

 1 of 2